Opticyte
Latest round
- Seed
Last raised
- Nov 2020
Total raised
- $1.7M
Investors
- 2
About Opticyte
Opticyte, Inc. is a medical technology company dedicated to improving patient outcomes through innovative monitoring solutions.Founded in 2016, Opticyte, Inc. is based in Seattle, US, focusing on advanced medical technologies. The company was established by Kenneth Schenkman.Opticyte specializes in advanced medical technologies, focusing primarily on its flagship product, the VitalO2 device. This innovative tool is designed to accurately monitor cellular oxygen levels in patients, addressing critical needs in the early detection and treatment of conditions such as sepsis, trauma, and respiratory failure. Unlike traditional pulse oximeters, which have demonstrated significant racial bias in diagnosing blood oxygen levels, the VitalO2 employs sophisticated machine learning algorithms trained on a diverse dataset to ensure reliable results across all skin tones.Opticyte's revenue model is primarily structured around direct sales of the VitalO2 device to healthcare institutions and medical facilities. The company engages in B2B transactions, supplying its technology to hospitals that are keen to enhance their diagnostic capabilities and improve patient outcomes. Revenue is generated through one-time equipment sales and may also include service agreements or educational partnerships that support the integration of the VitalO2 into existing clinical workflows.Opticyte plans to expand its product offerings with upcoming enhancements to the VitalO2 device, although specific release dates have not been disclosed. The company aims to penetrate new markets, specifically targeting additional healthcare facilities across the United States by 2023.6 mn will be utilized to support the development of these new products and to facilitate market expansion efforts.
Who invested in Opticyte
2 investors across 1 round
See all investors in Opticyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 1, 2020
Amount
$1.7M
Investors
Questions about Opticyte
Who invested in Opticyte?
Opticyte has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Opticyte raised?
Opticyte has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Opticyte last raise money?
Opticyte's most recent round on record is a Seed, in Nov 2020.
What does Opticyte do?
Opticyte is a medical devices & equipment company.
Where is Opticyte headquartered?
Opticyte is headquartered in Seattle, US.
Which VCs invest in companies like Opticyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Opticyte's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Opticyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.